Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comments on "Role of intestinal microbiota in the development of multiple sclerosis".
Cross-validation of oxygen uptake prediction during walking in ambulatory persons with multiple sclerosis.
Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy.
In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica-related pathology.
[Treatment of neuromyelitis optica].
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis.
The Multiple Sclerosis-Fatigue Self- Efficacy (MS-FSE) scale: initial validation.
Robot Therapy Tipping Point: Caveats for Post hoc Speculation.
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study.
"I knew what was going to happen if I did nothing and so I was going to do something": Faith, hope, and trust in the decisions of Canadians with multiple sclerosis to seek unproven interventions abroad.
Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.
Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorder.
Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair.
Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T.
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP).
Multiple sclerosis: getting personal with induced pluripotent stem cells.
Degenerative Cervical Myelopathy: A Spectrum of Related Disorders Affecting the Aging Spine.
Natural history of multiple sclerosis from the Indian perspective: Experience from a tertiary care hospital.
Pertussis toxin promotes relapsing-remitting experimental autoimmune encephalomyelitis in Lewis rats.
DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.
1H-Magnetic Resonance Spectroscopy in diffuse and focal cervical cord lesions in Multiple Sclerosis.
[The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].
A reliability study of colour-Doppler sonography for the diagnosis of chronic cerebrospinal venous insufficiency shows low inter-rater agreement.
Eicosapentaenoic acid pre-treatment reduces biochemical changes induced in total brain and myelin of weanling Wistar rats by cuprizone feeding.
Pages
« first
‹ previous
…
539
540
541
542
543
544
545
546
547
…
next ›
last »